Ipamorelin and sermorelin both aim to raise natural growth hormone output, but they act on different receptors and carry very different regulatory status at telos rx today.
Ipamorelin is a ghrelin receptor agonist. Sermorelin is a growth hormone releasing hormone analog. Both prompt the pituitary gland to release more growth hormone, but through separate biological pathways with separate research histories. Telos rx currently offers sermorelin as a compounded protocol. Telos rx does not currently offer ipamorelin, so this article compares the two honestly rather than treating them as interchangeable.
Two different doors to the same hormone
Growth hormone release from the pituitary gland is controlled by more than one signal in the body.
Sermorelin mimics growth hormone releasing hormone, the natural signal that tells the pituitary gland to produce and release growth hormone on its normal pulsing schedule.
Ipamorelin instead targets the ghrelin receptor, a separate pathway that also triggers growth hormone release but through a different chain of signaling inside the pituitary.
Both approaches raise growth hormone output. They simply knock on different doors to get there, which is part of why researchers study them separately rather than as one interchangeable category.
Where the clinical history differs
Sermorelin has the longer track record. It was studied and used as a diagnostic and treatment tool for growth hormone deficiency going back several decades.
That history gives providers a much larger body of human data to draw on when reviewing a patient's history and deciding whether a sermorelin protocol makes sense.
Ipamorelin is a newer synthetic peptide with a smaller human trial record, even though its pharmacology has been studied for years in a research setting.
A longer clinical history is not the only thing that matters, but it is a real difference, and it is part of why telos rx currently offers one and not the other.
Why telos rx offers one but not the other
Telos rx currently offers sermorelin as a compounded, medically supervised protocol through its partner compounding pharmacies.
Telos rx does not currently offer ipamorelin. You can read more about telos rx's current status on ipamorelin directly.
Ipamorelin is under review as part of the broader research peptide category telos rx continues to evaluate, and inclusion in the program is not confirmed or scheduled.
A 2026 committee review made non-binding recommendations regarding several research peptides. That is a recommendation, not a regulatory approval, and it has not changed what telos rx currently offers.
How the reported effects compare
People researching both peptides tend to describe similar categories of interest: sleep quality, recovery, and body composition over time.
Sermorelin's effects come from restoring a more natural growth hormone release pattern, working with the body's existing pulsing rhythm rather than overriding it.
Ipamorelin's proposed appeal is a more specific action on the ghrelin receptor, with less effect on cortisol and other pituitary hormones than some older growth hormone secretagogues.
Outcomes are not guaranteed for either peptide, and any real protocol depends on a licensed provider's evaluation of your history and goals rather than a general comparison like this one.
Side effect considerations reported in the literature
Published research on growth hormone secretagogues as a class describes injection site reactions, temporary flushing, and changes in appetite as commonly reported effects.
Because sermorelin has a longer clinical history, more of what is known about its side effect pattern comes from actual patient use rather than early research settings.
Ipamorelin's side effect profile is described in the literature as comparatively mild relative to older secretagogues, though the human data behind that claim remains more limited.
A licensed provider is the right person to walk through what to expect and what warrants a call to your care team, not a general comparison article.
How each one is dosed, in general terms
Growth hormone secretagogues are typically described in the literature as subcutaneous injections given on a repeating schedule rather than a single dose.
The exact frequency, timing, and amount used in any real protocol depends on the specific product, the person's goals, and a provider's clinical judgment.
General dosing patterns reported for research purposes are not a substitute for a plan built around your own history, and a licensed provider is the appropriate source for that plan.
Sermorelin's dosing at telos rx is set by a licensed provider as part of an evaluated protocol, not copied from a forum post or a generic online guide.
Key takeaway: Ipamorelin and sermorelin raise growth hormone through different receptors and carry very different regulatory status at telos rx. Sermorelin is available today with a longer clinical history behind it, while ipamorelin remains under review.
A note on why comparisons like this get exaggerated online
Peptide forums and seller pages frequently frame comparisons as a clear winner and a clear loser.
That framing is easier to sell than a nuanced answer, even when it does not reflect the underlying research well.
In reality, sermorelin and ipamorelin were developed to solve overlapping but not identical problems, and the honest comparison depends heavily on the specific person and their history.
A provider evaluating your case is working from your actual labs and history, not from a generic ranking of which peptide performs better in the abstract.
That is a meaningful difference between reading about peptides casually and actually being evaluated for one.
Cost and access are part of the real comparison
Telos rx offers sermorelin starting as low as $125 a month.
It is dispensed through partner compounding pharmacies with asynchronous intake and no in-person visit required.
Ipamorelin has no equivalent access point at telos rx right now.
Any comparison of price or convenience is somewhat academic until that changes, if it ever does.
For readers weighing the two, the practical question today is less which peptide is theoretically better and more which one you can actually start under medical supervision.
How telos rx's review process works, in general terms
Telos rx evaluates research peptides against regulatory status, sourcing reliability through its partner compounding pharmacies, and the strength of the available safety data.
That review happens independently for each substance, so a decision about one peptide does not automatically carry over to a related one, even when the two are frequently compared online.
Ipamorelin's review sits within that broader process, and its outcome is not tied to sermorelin's already-established place in the current compounding program.
What would change the picture
Ipamorelin's status could shift if telos rx completes its review of research peptides.
That would mean deciding to add it to the compounding program, though no timeline for that decision currently exists.
Regulatory clarity at the federal level, beyond the non-binding 2026 committee recommendations, would also factor into that review.
Until then, sermorelin remains the growth hormone pathway telos rx can actually offer with full medical oversight behind it.
If you are ready to start a growth hormone protocol
Telos rx currently offers four compounded peptide options for patients ready to start today.
Those are BPC-157, PT-141, NAD+ nasal spray, and sermorelin.
Sermorelin is the closest available option to what people researching ipamorelin are usually after, since both work toward the same goal of higher natural growth hormone output.
Start an online visit for sermorelin if that fits what you are looking for.
Approval is subject to evaluation by a licensed provider, and any protocol is tailored to your own history rather than assumed from a general comparison.
For background on how growth hormone secretagogues have been studied, see the NIH review of growth hormone secretagogues. For how compounded medication is regulated, see the FDA overview of drug compounding.
Frequently Asked Questions
Is ipamorelin stronger than sermorelin?
Neither peptide is simply stronger than the other. They act on different receptors, and comparing potency directly is not straightforward without controlled head-to-head research in people, which does not currently exist at meaningful scale. Framing it as a strength contest tends to oversimplify how each one actually works in the body.
Can I take ipamorelin and sermorelin together?
Telos rx does not currently offer ipamorelin, so this is not a combination telos rx can provide guidance on or dispense. Any decision about combining peptides should go through a licensed provider.
Why does telos rx offer sermorelin but not ipamorelin?
Sermorelin has a longer clinical history and is currently part of telos rx's compounding program. Ipamorelin remains under review as part of the broader research peptide category and is not yet part of the program.
Does sermorelin work the same way as ipamorelin?
No. Sermorelin mimics growth hormone releasing hormone directly, while ipamorelin acts on the ghrelin receptor through a separate signaling pathway. Both raise growth hormone output but through different mechanisms, which is why they are studied as distinct compounds rather than variations on one another.
Will telos rx add ipamorelin in the future?
There is no confirmed timeline. Telos rx continues to review research peptides, including ipamorelin, but inclusion in the compounding program is not scheduled and not guaranteed.
What should I do if I am interested in a growth hormone protocol now?
Ask about sermorelin, which telos rx currently offers as a compounded, medically supervised option through partner compounding pharmacies with asynchronous intake.
TelosRX is LegitScript-certified. Compounded medication is not FDA-approved and is prepared under federal compounding regulations. This article is general information, not medical advice, and does not replace guidance from your own provider. TelosRX operates as an online-first, asynchronous telehealth service.
Questions about how sermorelin compares to what you have read about ipamorelin? Explore telos rx's sermorelin page, or visit telosrx.com to see the full current product lineup.